TABLE OF CONTENTS
To assist you in your deliberations, we have prepared
the following items for review:
Tab 1 – September 19 Drug Safety and Risk Management Meeting Draft
Agenda
Tab 2 – Executive Summary
Tab 3 – Issues for Discussion
Tab 4 – Federal Register Notices
Tab 5 – June 26, 2003 Meeting, Written Comments
Tab 6 –
Tab 7 –
Tab 8 – “The Role of Pharmaceutical
Trademarks in Medication Errors”
Book Excerpt: Medication
Errors, Cohen, MR, 1999, Chapter 12
American
Pharmaceuticals Association,
Tab 9 – Center for Drug Evaluation Research
(CDER) Medication Errors
Page
Tab 10 –
“Use Caution, Avoid Confusion”